Sector Gamma AS Increases Stake in Humana Inc. (NYSE:HUM)

Sector Gamma AS grew its position in Humana Inc. (NYSE:HUM) by 16.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,000 shares of the insurance provider’s stock after acquiring an additional 2,000 shares during the quarter. Humana comprises about 1.2% of Sector Gamma AS’s portfolio, making the stock its 24th largest position. Sector Gamma AS’s holdings in Humana were worth $3,552,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in HUM. FPC Investment Advisory Inc. purchased a new stake in shares of Humana in the fourth quarter valued at $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana in the fourth quarter worth about $30,000. LFA Lugano Financial Advisors SA grew its holdings in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the last quarter. OFI Invest Asset Management bought a new position in shares of Humana in the fourth quarter worth about $33,000. Finally, Atwood & Palmer Inc. grew its holdings in shares of Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on HUM shares. Morgan Stanley cut their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. StockNews.com cut shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday. Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Piper Sandler increased their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, Humana has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Price Performance

NYSE HUM opened at $266.62 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock’s fifty day moving average price is $271.39 and its 200 day moving average price is $278.13. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The company has a market cap of $32.18 billion, a price-to-earnings ratio of 26.80, a PEG ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s payout ratio is 35.58%.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.37% of the stock is owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.